Different Effects of Antihypertensive Therapies Based on Losartan or Atenolol on Ultrasound and Biochemical Markers of Myocardial Fibrosis: Results of a Randomized Trial

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Circulation

• Publication date

  2004-08-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000137118.47943.5CPMID 15277331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incremental Value of Ultrasonic Tissue Characterization (Backscatter) in the Evaluation of Left Ventricular Myocardial Structure and Mechanics in Essential Arterial Hypertension

  2003cited by this paper
• Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy

  2002cited by this paper
• Ultrasonic Backscatter and Serum Marker of Cardiac Fibrosis in Hypertensives

  2002cited by this paper
• Losartan-Dependent Regression of Myocardial Fibrosis Is Associated With Reduction of Left Ventricular Chamber Stiffness in Hypertensive Patients

  2002cited by this paper
• Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

  2002cited by this paper
• Usefulness of Serum Carboxy-Terminal Propeptide of Procollagen Type I in Assessment of the Cardioreparative Ability of Antihypertensive Treatment in Hypertensive Patients

  2001cited by this paper
• Fibrosis and hypertensive heart disease

  2000cited by this paper
• Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan.

  2000cited by this paper
• Lisinopril-Mediated Regression of Myocardial Fibrosis in Patients With Hypertensive Heart Disease

  2000cited by this paper
• Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs.

  2000cited by this paper
• Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease.

  2000cited by this paper
• Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease.

  2000cited by this paper
• Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats.

  1999cited by this paper
• Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans

  1998cited by this paper
• Abnormalities of the extracellular degradation of collagen type I in essential hypertension.

  1998cited by this paper
• Echocardiographic patterns of myocardial fibrosis in hypertensive patients: endomyocardial biopsy versus ultrasonic tissue characterization.

  1997cited by this paper
• Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis.

  1996cited by this paper
• Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations.

  1995cited by this paper
• Myocyte cellular hypertrophy is responsible for ventricular remodelling in the hypertrophied heart of middle aged individuals in the absence of cardiac failure.

  1994cited by this paper
• Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.

  1994cited by this paper
• Cardioreparative Effects of Lisinopril in Rats With Genetic Hypertension and Left Ventricular Hypertrophy

  1991cited by this paper
• In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans.

  1990cited by this paper
• Image analysis for all

  1990cited by this paper
• Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass.

  1987cited by this paper
• Statistical methods for assessing agreement between two methods of clinical measurement.

  1986cited by this paper
• Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy.

  1986cited by this paper
• The dependence of myocardial ultrasonic integrated backscatter on contractile performance.

  1985cited by this paper
• Muscle fiber orientation and connective tissue content in the hypertrophied human heart.

  1982cited by this paper
• The Dependence of Ultrasonic Attenuation and Backscatter on Collagen Content in Dog and Rabbit Hearts

  1980cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Angiotensin-Converting Enzyme-2 (ACE2) Downregulation During Coronavirus Infection

  2024cites this paper
• Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function

  2024cites this paper
• Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies.

  2023cites this paper
• Fibroblasts under pressure: Cardiac fibroblast responses to hypertension and antihypertensive therapies.

  2023cites this paper
• Identification of Gene Expression Signatures for Phenotype-Specific Drug Targeting of Cardiac Fibrosis

  2023cites this paper
• Targeting Myocardial Fibrosis—A Magic Pill in Cardiovascular Medicine?

  2022cites this paper
• Effect of Perindopril on Atrial Fibrillation Recurrence and Burden: Results of the Canadian Trial of Atrial Fibrillation (CTAF)-2

  2021cites this paper
• Effects of inhibition of the renin-angiotensin system on hypertension-induced target organ damage: clinical and experimental evidence.

  2021cites this paper
• Current and Emerging Classes of Pharmacological Agents for the Management of Hypertension

  2021cites this paper
• Coronavirus uses as binding site in humans angiotensin‐converting enzyme 2 functional receptor that is involved in arterial blood pressure control and fibrotic response to damage and is a drug target in cardiovascular disease. Is this just a phylogenetic coincidence?

  2020cites this paper
• SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs

  2020cites this paper
• The puzzle of sharing bio-molecular targets between coronaviruses and mediators of the cardiovascular system in humans: Looking for plausible hypotheses

  2020cites this paper
• Long-term effect of the perindopril/indapamide/amlodipine single-pill combination on left ventricular hypertrophy in outpatient hypertensive subjects

  2019cites this paper
• Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts

  2019cites this paper
• Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis

  2019cites this paper
• Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.

  2019cites this paper
• Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement.

  2019cites this paper
• Regression of Established Cardiac Fibrosis in Hypertensive Heart Disease

  2017cites this paper
• Hemodynamic effects of renin-angiotensin-aldosterone inhibitor and β-blocker combination therapy vs. β-blocker monotherapy for portal hypertension in cirrhosis: A meta-analysis.

  2017cites this paper
• Circulating Biomarkers of Collagen Metabolism and Prognosis of Heart Failure with Reduced or Mid-Range Ejection Fraction.

  2017cites this paper
• Effects of losartan on left ventricular mass: a three-year follow-up in elderly hypertensives with myocardial hypertrophy despite successful conventional antihypertensive treatment.

  2017cites this paper
• Mechanisms of Fibroblast Activation in the Remodeling Myocardium

  2017cites this paper
• Management of Hypertension Using Olmesartan Alone or in Combination

  2017cites this paper
• Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity

  2016cites this paper
• receptor antagonist losartan and its combination with diuretics on myocardial morpho-functional conditions in hypertensive patients with left ventricular hypertrophy ВЛИЯНИЕ БЛОКАТОРА РЕЦЕПТОРОВ АНГИОТЕНЗИНА II ЛОЗАРТАНА И ЕГО КОМБИНАЦИИ С ДИУРЕТИКОМ СОСТОЯНИЕ АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ ЛЕВОГО ЖЕЛУДОЧ

  2016cites this paper
• Persistent phenotypic shift in cardiac fibroblasts: impact of transient renin angiotensin system inhibition.

  2016cites this paper
• Atrial Dilatation Development in Hypertensive Treated Patients: The Campania-Salute Network.

  2016cites this paper
• Procollagen type III amino terminal peptide and myocardial fibrosis: A study in hypertensive patients with and without left ventricular hypertrophy.

  2015cites this paper
• Telmisartan inhibited angiotensin II-induced collagen metabolic imbalance without directly targeting TGF-β 1/Smad signaling pathway in cardiac fibroblasts.

  2015cites this paper
• Biomarkers of the extracellular matrix and of collagen fragments.

  2015cites this paper
• RENALNA DENERVACIJA KAO METODA LIJEČENJA REZISTENTNE HIPERTENZIJE

  2014cites this paper
• Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes.

  2014cites this paper
• Potential Reduction of Interstitial Myocardial Fibrosis With Renal Denervation

  2014cites this paper
• Progression of diffuse myocardial fibrosis assessed by cardiac magnetic resonance T1 mapping

  2014cites this paper
• Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway

  2014cites this paper
• Effect of telmisartan on atrial fibrillation recurrences in patients with hypertension: a systematic review and meta-analysis.

  2014cites this paper
• Renalna denervacija kao metoda liječenja rezistentne hipertenzije

  2014cites this paper
• Beta Blockers are Good Choice as First line Antihypertensive Agents

  2013cites this paper
• Effect of Telmisartan and Ramipril on Atrial Fibrillation Recurrence and Severity in Hypertensive Patients With Metabolic Syndrome and Recurrent Symptomatic Paroxysmal and Persistent Atrial Fibrillation

  2012cites this paper
• Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome.

  2012cites this paper
• The role of stress test for predicting genetic mutations and future cardiac events in asymptomatic relatives of catecholaminergic polymorphic ventricular tachycardia probands.

  2012cites this paper
• Specific Features of Target Organ Damage in Patients with Arterial Hypertension and Coronary Artery Disease

  2012cites this paper
• Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes

  2012cites this paper
• Pathophysiological consequences of hypertension in the cardiovascular system Longstanding hypertension

  2012cites this paper
• Exercise-Induced Arrhythmias

  2012cites this paper
• Comparison of the effects of angiotensin II receptor antagonist monotherapy and combination therapy with a diuretic on cardiac function in spontaneously hypertensive rats

  2012cites this paper
• Mechanical stretch up-regulates the B-type natriuretic peptide system in human cardiac fibroblasts: a possible defense against transforming growth factor-β mediated fibrosis

  2012cites this paper
• Cardiovascular magnetic resonance in systemic hypertension

  2012cites this paper
• Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.

  2012cites this paper
• A Clinical Approach to Inherited Arrhythmias

  2012cites this paper
• Reverse remodeling in heart failure—mechanisms and therapeutic opportunities

  2012cites this paper
• The Role of Beta-Blockers as First-Line Therapy in Hypertension

  2011cites this paper
• Telmisartan Versus Valsartan in Patients With Hypertension: Effects on Cardiovascular, Metabolic, and Inflammatory Parameters

  2011cites this paper
• Effect of furosemide on left ventricular mass in non-dialysis chronic kidney disease patients: a randomized controlled trial.

  2011cites this paper
• CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis.

  2011cites this paper
• The Effect of Losartan and Amlodipine on Left Ventricular Diastolic Function and Atherosclerosis in Japanese Patients with Mild-to-Moderate Hypertension (J-ELAN) study

  2011cites this paper
• Natriuretic peptides and collagen biomarkers in patients with medical treatment for hypertension

  2011cites this paper
• Intracellular Calcium Handling and Inherited Arrhythmogenic Diseases

  2011cites this paper
• Effects of Eprosartan on Diastolic Function and Neurohormones in Patients with Hypertension and Diastolic Dysfunction

  2010cites this paper
• Prevention, diagnosis, and treatment of hypertensive heart disease.

  2010cites this paper
• Filling Pressures and Collagen Metabolism in Hypertensive Patients With Heart Failure and Normal Ejection Fraction

  2010cites this paper
• The restoration of chronotropic competence in heart failure patients with normal ejection fraction (RESET) study: rationale and design.

  2010cites this paper
• Candesartan Decreases Type III Procollagen-N-Peptide Levels and Inflammatory Marker Levels and Maintains Sinus Rhythm in Patients With Atrial Fibrillation

  2010cites this paper
• Is There a Role for Echocardiography in Intracerebral Haemorrhage?

  2010cites this paper
• Circulating Biomarkers of Collagen Metabolism in Cardiac Diseases

  2010cites this paper
• Clinical Trials: Methods and Design The Restoration of Chronotropic CompEtence in Heart Failure PatientS with Normal Ejection FracTion (RESET) Study: Rationale and Design

  2010cites this paper
• Catecholaminergic Polymorphic Ventricular Tachycardia.

  2010cites this paper
• Clinical characteristics of three Czech families with catecholaminergic polymorphic ventricular tachycardia and pilot results of RyR2 gene mutation analysis

  2010cites this paper
• Effects of renin-angiotensin system inhibition on left atrial function of hypertensive patients: an echocardiographic tissue deformation imaging study.

  2010cites this paper
• Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction.

  2010cites this paper
• Anti-hypertensive drugs and left ventricular hypertrophy: a clinical update

  2010cites this paper
• Extracellular matrix fibrotic markers in heart failure

  2010cites this paper
• Why beta-blockers should not be used as first choice in uncomplicated hypertension.

  2010cites this paper
• Catecholaminergic polymorphic ventricular tachycardia: A paradigm to understand mechanisms of arrhythmias associated to impaired Ca(2+) regulation.

  2009cites this paper
• Perindopril decreases P wave dispersion in patients with stage 1 hypertension

  2009influential citation
• Beta-blockers as first-line antihypertensive therapy the crumbling continues.

  2009cites this paper
• Atrial remodeling in atrial fibrillation : Epidemiological, clinical and magnetocardiographic aspects

  2009cites this paper
• The Long QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia *

  2009cites this paper
• Pleiotropic effects of drugs inhibiting the renin-angiotensin-aldosterone system.

  2009cites this paper
• A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: the REZALT study

  2009cites this paper
• Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angiotensin-converting enzyme inhibitor, enalapril

  2009cites this paper
• Histopathological study of specimens obtained by left ventricular biopsy during ventriculoplasty for idiopathic dilated cardiomyopathy.

  2009cites this paper
• The Impact of Reducing Hypertensive Left Ventricular Hypertrophy on Sudden Cardiac Death

  2009cites this paper
• Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction.

  2009cites this paper
• Biomarkers of extracellular matrix turnover.

  2009cites this paper
• Effects of AT1‐ and β‐adrenergic receptor antagonists on TGF‐β1‐induced fibrosis in transgenic mice

  2009cites this paper
• Choice of antihypertensive drugs in the European Society of Hypertension-European Society of Cardiology guidelines: specific indications rather than ranking for general usage.

  2008cites this paper
• Molecular genetics of sudden cardiac death.

  2008cites this paper
• Diastolic heart failure in the elderly: underlying mechanisms and clinical relevance.

  2008cites this paper
• Europejskie wytyczne dotyczące prewencji chorób sercowo-naczyniowych w praktyce klinicznej - wersja skrócona Czwarta Wspólna Grupa Robocza Europejskiego Towarzystwa Kardiologicznego i innych towarzystw do spraw prewencji chorób sercowo-naczyniowych w praktyce klinicznej

  2008cites this paper
• Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy.

  2008cites this paper
• Guías de práctica clínica sobre prevención de la enfermedad cardiovascular. Versión corregida 22/07/2009

  2008cites this paper
• The effects of losartan on signal-averaged P wave in patients with atrial fibrillation.

  2008cites this paper
• Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation.

  2008cites this paper
• Catecholaminergic polymorphic ventricular tachycardia.

  2008cites this paper
• Chapter 27 – Role of Neurohormones

  2008cites this paper
• New Advances in Molecular Therapy for Muscle Repair After Diseases and Injuries

  2008cites this paper
• Noninvasive Assessment of Left Atrial Function by Strain Rate Imaging in Patients with Hypertension: A Possible Beneficial Effect of Renin-Angiotensin System Inhibition on Left Atrial Function

  2008cites this paper
• Zur Bedeutung der linksventrikulären Hypertrophie bei arterieller Hypertonie im Praxisalltag - Focus auf das LIL-Projekt

  2008cites this paper
• Comparative Evaluation of Effect of Valsartan/Amlodipine and Atenolol/Amlodipine Combinations on Atrial Fibrillation Recurrence in Hypertensive Patients With Type 2 Diabetes Mellitus

  2008cites this paper